Toxicogenomics and toxic torts

    Research output: Contribution to journalArticle

    29 Citations (Scopus)

    Abstract

    One of the first practical applications of toxicogenomics will probably be in the context of toxic tort personal injury litigation. Gene expression changes that'fingerprint' exposure to particular classes of toxic substances can potentially be used to demonstrate exposure, prove causation and support novel damage claims in lawsuits brought by citizens injured by toxic exposures. Although the potential use of toxicogenomic data in toxic tort litigation is immense, there is a danger of premature use of such data before they have been adequately validated and characterized.

    Original languageEnglish (US)
    Pages (from-to)329-332
    Number of pages4
    JournalTrends in Biotechnology
    Volume20
    Issue number8
    DOIs
    StatePublished - Aug 1 2002

    Fingerprint

    Toxicogenetics
    Legal Liability
    Poisons
    Jurisprudence
    Gene expression
    Dermatoglyphics
    Causality
    Gene Expression
    Wounds and Injuries

    ASJC Scopus subject areas

    • Bioengineering

    Cite this

    Toxicogenomics and toxic torts. / Marchant, Gary.

    In: Trends in Biotechnology, Vol. 20, No. 8, 01.08.2002, p. 329-332.

    Research output: Contribution to journalArticle

    Marchant, Gary. / Toxicogenomics and toxic torts. In: Trends in Biotechnology. 2002 ; Vol. 20, No. 8. pp. 329-332.
    @article{e9950f8d4c604232b7632883b2eb3cfc,
    title = "Toxicogenomics and toxic torts",
    abstract = "One of the first practical applications of toxicogenomics will probably be in the context of toxic tort personal injury litigation. Gene expression changes that'fingerprint' exposure to particular classes of toxic substances can potentially be used to demonstrate exposure, prove causation and support novel damage claims in lawsuits brought by citizens injured by toxic exposures. Although the potential use of toxicogenomic data in toxic tort litigation is immense, there is a danger of premature use of such data before they have been adequately validated and characterized.",
    author = "Gary Marchant",
    year = "2002",
    month = "8",
    day = "1",
    doi = "10.1016/S0167-7799(02)01992-3",
    language = "English (US)",
    volume = "20",
    pages = "329--332",
    journal = "Trends in Biotechnology",
    issn = "0167-7799",
    publisher = "Elsevier Limited",
    number = "8",

    }

    TY - JOUR

    T1 - Toxicogenomics and toxic torts

    AU - Marchant, Gary

    PY - 2002/8/1

    Y1 - 2002/8/1

    N2 - One of the first practical applications of toxicogenomics will probably be in the context of toxic tort personal injury litigation. Gene expression changes that'fingerprint' exposure to particular classes of toxic substances can potentially be used to demonstrate exposure, prove causation and support novel damage claims in lawsuits brought by citizens injured by toxic exposures. Although the potential use of toxicogenomic data in toxic tort litigation is immense, there is a danger of premature use of such data before they have been adequately validated and characterized.

    AB - One of the first practical applications of toxicogenomics will probably be in the context of toxic tort personal injury litigation. Gene expression changes that'fingerprint' exposure to particular classes of toxic substances can potentially be used to demonstrate exposure, prove causation and support novel damage claims in lawsuits brought by citizens injured by toxic exposures. Although the potential use of toxicogenomic data in toxic tort litigation is immense, there is a danger of premature use of such data before they have been adequately validated and characterized.

    UR - http://www.scopus.com/inward/record.url?scp=0036680463&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0036680463&partnerID=8YFLogxK

    U2 - 10.1016/S0167-7799(02)01992-3

    DO - 10.1016/S0167-7799(02)01992-3

    M3 - Article

    C2 - 12127279

    AN - SCOPUS:0036680463

    VL - 20

    SP - 329

    EP - 332

    JO - Trends in Biotechnology

    JF - Trends in Biotechnology

    SN - 0167-7799

    IS - 8

    ER -